首页 | 本学科首页   官方微博 | 高级检索  
     


RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells
Authors:Jessica J Mezzanotte  Victoria Hill  M Lee Schmidt  Thoraia Shinawi  Stella Tommasi  Dietmar Krex  Gabriele Schackert  Gerd P Pfeifer  Farida Latif  Geoffrey J Clark
Affiliation:1.Departments of Biochemistry/Pharmacology Toxicology; University of Louisville; Louisville, KY USA;2.School of Clinical and Experimental Medicine; University of Birmingham; Birmingham, UK;3.Department of Neurosurgery; University Hospital Carl Gustav Carus Dresden; Technical University of Dresden; Dresden, Germany;4.Department of Cancer Biology; Beckman Research Institute of the City of Hope; Duarte, CA USA
Abstract:Brain metastasis is a major contributor to cancer mortality, yet, the genetic changes underlying the development of this capacity remain poorly understood. RASSF proteins are a family of tumor suppressors that often suffer epigenetic inactivation during tumorigenesis. However, their epigenetic status in brain metastases has not been well characterized. We have examined the promoter methylation of the classical RASSF members (RASSF1A-RASSF6) in a panel of metastatic brain tumor samples. RASSF1A and RASSF2 have been shown to undergo promoter methylation at high frequency in primary lung and breast tumors and in brain metastases. Other members exhibited little or no methylation in these tumors. In examining melanoma metastases, however, we found that RASSF6 exhibits the highest frequency of inactivation in melanoma and in melanoma brain metastases. Most melanomas are driven by an activating mutation in B-Raf. Introduction of RASSF6 into a B-RafV600E-containing metastatic melanoma cell line inhibited its ability to invade through collagen and suppressed MAPK pathway activation and AKT. RASSF6 also appears to increase the association of mutant B-Raf and MST1, providing a potential mechanism by which RASSF6 is able to suppress MAPK activation. Thus, we have identified a novel potential role for RASSF6 in melanoma development. Promoter methylation leading to reduced expression of RASSF6 may play an important role in melanoma development and may contribute to brain metastases.
Keywords:brain metastases   invasion   melanoma   MAPK   Ras   RASSF
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号